This patent covers the use of various endothelial stem cells, and stem cells that resemble hematopoietic stem cells, for the stimulation of angiogenesis.
Cell types covered include: CD34+, Tie+, or flk-1+.
Methods of expanding the cells in vitro prior to implantation are also disclosed.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.